US Dollar Back on the Offensive as Key Inflation Data Looms


(MENAFN- DailyFX) Talking Points:

returns to the offensive as PCE data looms ahead may rise if upbeat CPI data boosts bets on QE unwind UK GDP upgrade might bolster Pound on rate hike outlook The underperformed in Asia Pacific trade, falling against all of its major counterparts in a move that seemed to be corrective following the previous day's outsized gains. The likewise traded lower after the .

On the other side of the spectrum, the US Dollar traded broadly higher against its G10 FX peers. The benchmark unit appeared to have after four consecutive days of gains in the prior session but now seems to be on the offensive once again.

Augusts' PCE inflation data the Fed's favored price growth gauge is now in focus. The headline on-year rate is expected to rise for the first time in six months, hitting 1.5 percent. If the figures follow the lead of analogous CPI statistics and overshoot the forecast, the greenback might find fresh fuel for gains.

Eurozone CPI headlines the European data docket, with the year-on-year inflation rate seen rising to a five-month high at 1.6 percent. A better-than-expected outcome echoing recently rosy regional news-flow may boost the Euro as traders position for the unwinding of QE asset purchases in the near term.

A revised second-quarter UK GDP reading is also on tap. Here too, recent data outcomes have conspicuously improved relative to analysts' expectations over the past six weeks. If this foreshadows an upgrade, the may rise as BOE rate hike speculation heats up anew.

What is the #1 mistake that traders make, and how do fix it? !

Asia Session

European Session

** All times listed in GMT. See the .

--- Written by Ilya Spivak, Currency Strategist for DailyFX.com

To receive Ilya's analysis directly via email, please

Contact and follow Ilya on Twitter:



Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.